Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Pfizer
Pfizer
Emory University
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
Altor BioScience